23/09/2025
Experts Outline the Healthcare, Policy, and Social Changes Needed to Fully Harness Advances in Alzheimer’s Treatment
The approval of new antibody-based drugs for Alzheimer’s disease—lecanemab and donanemab—and of blood-based diagnostic tests marks the beginning of a new era in the diagnosis and treatment of th...